Affymetrix Discloses 10 Percent Stake Held by Mazama

May 13, 2008

NEW YORK (GenomeWeb News) – Mazama Capital Management owns a 10 percent stake in Affymetrix’s Class A common stock, according to a filing with the US Securities and Exchange Commission today.

The Portland, Oregon-based investment advisory firm owned 6,783,041 shares of Affy’s common stock as of April 15.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

NIH's Collins on Harassment

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

With Eight Arms and Giant Eyes

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Missing From Trials

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

This Week in Cell

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.

Main menu